In part 2 of a series examining “America’s losing battle against diabetes,” Reuters reports on “an epidemic of hypoglycemia among Americans with diabetes that has resulted in millions of medical emergencies and thousands of deaths. This epidemic, a Reuters investigation has found, was fueled by a drug industry campaign that began two decades ago to promote an aggressive diabetes treatment goal – the A1c below 7% that Carlson strived to reach.” In 1993 the NIH funded “a 10-year study of type 1 patients who lowered their average blood glucose over time to an A1c of 7%. The treatment, the study concluded, reduced the risk of eye, nerve, and kidney damage.” The article says, “That fueled enthusiasm among researchers, regulators, and the ADA for A1c as a key health measure.”

From the news release of the American Association for Justice.